INTRODUCTION
============

According to the statistics of the National Health and Nutrition Examination Survey, the prevalence of arthritis in the Republic of Korea was 37.3% in the over 50 years of age, and differed depending on gender and age \[[@B1][@B2]\]. Osteoarthritis, the most common arthritis, is a degenerative joint disease characterized by joint pain and swelling through gradual loss of articular cartilage. Age, sex, family history, joint stress, and obesity are major contributing factors to the development of osteoarthritis. It can lower the quality of life by inhibiting daily activities and causing movement disorders \[[@B3]\].

Degenerative osteoarthritis occurs in the damaged joint when chondrocytes, joint cartilage cells, activate the synthesis of the matrix proteinase components and degradation of cartilage matrix. Factors associated with activation of chondrocytes are protein hydrolysis enzyme (proteolytic enzymes), cytokines, and nitric oxide (NO). Pro-inflammatory cytokines cause the expression of proteases such as collagenase, aggrecanase, and matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs), and then the activation of protease induces the degradation of the collagen matrix of cartilage and impairment of procollagen synthesis. In addition, pro-inflammatory cytokines plays an extremely important role in the development of inflammation by production of prostaglandin E~2~ (PGE~2~) and NO \[[@B4][@B5][@B6][@B7]\].

Therefore, pharmacologic interventions have focused on anti-inflammation and pain relief by non-steroidal anti-inflammatory drug (NSAID) and corticosteroids. However, due to side effects of the pharmacologic interventions, the demand for health functional food is increasing rapidly. Accordingly, the market for health functional food associated with osteoarthritis has been persistently maintained, expectations of finding a new functionality of health functional food ingredients have increased \[[@B8][@B9][@B10][@B11]\].

*Hijikia fusiforme* is brown seaweed widely distributed in Japan, Korea, and China. \[[@B12]\]. Laminaran and fucoidan are the major constituents of *Hijikia fusiforme*, which has biological effects of blood coagulation, immune regulation, prevention of cholesterol deposits in blood vessels, and anti-cancer \[[@B12][@B13][@B14][@B15][@B16]\]. Jeong et al. \[[@B16]\] reported that *Hijikia fusiforme* induced NO production and enhancement of pro-inflammatory cytokines in Raw 264.7 cells and splenocytes. However, improving in osteoarthritis requires the opposite for anti-inflammation, such as reductions of NO and pro-inflammatory cytokines. In this study, the preventive effects of *Hijikia fusiforme* against osteoarthritis induced by monosodium iodoacetate (MIA) injection in rats were examined. The effects of oral administration of *Hijikia fusiforme* on anti-inflammation were examined by measuring levels of pro-inflammatory cytokine, nitric oxide, PGE~2~, and gene expression.

MATERIALS AND METHODS
=====================

Preparation of Hijikia fusiforme
--------------------------------

Fresh *Hijikia fusiforme* was purchased from a commercial supplier in Wando, Republic of Korea. The fresh *Hijikia fusiforme* (60 kg) was dried for 3 days at room temperature after washing in tap water, yielding 6 kg of dried *Hijikia fusiforme*. The dried *Hijikia fusiforme* (HF) was extracted with 20 volumes of water at 100℃ for 4 h, and 30% or 80% ethanol at 20℃ for 12 h in a reflux apparatus. Extracts were filtered using Whatman (Maidstone, United Kingdom) paper (NO. 2) and concentrated at 50℃ using rotary evaporators under reduced pressure. The concentrate was freeze-dried, and yields of *Hijikia fusiforme* water extract (HW), *Hijikia fusiforme* 20% ethanol extract (ET20), and *Hijikia fusiforme* 50% ethanol extract (ET50) were 6.5%, 4.8%, and 3.6%, respectively. Each extract was stored in a tight and light-protected container at -20℃ until used.

Primary culture of chondrocyte
------------------------------

The study was approved by the Institutional Animal Care and Use Committee of Kyung Hee University (KHUASP(SE)-15-020). Six week male Sprague-Dawley rats (160-180 g) were sacrificed by cervical dislocation under ether anesthesia and both tibiae were dissected free. Cartilage were separately sliced and incubated at room temperature in Hank\'s balanced salt solution (HBSS, Hyclone Laboratories, Logan, Utah, USA) containing 2 mg/mL collagenase (SERVA, Heidelberg, Germany), and overnight in a shaker at 100 rpm. The chondrocytes obtained by this method were seeded on a 75T flask in DMEM medium (Hyclone Laboratories, Logan, Utah, USA) with 10% fetal bovine serum (FBS, Hyclone Laboratories, Logan, Utah, USA), 50 µL gentamycin sulfate (Hyclone Laboratories, Logan, Utah, USA) and cells were cultured in a 5% CO~2~ incubator at 35℃.

Cell viability
--------------

Cell viability was assessed using 3-(4,5-dimethylthiazol-2yl-)-2,5-diphenyl tetrazolium bromide (MTT) (Sigma Aldrich, Sigma, St. Louis, MO, USA). Primary chondrocytes were cultured with extracts at various concentrations. After incubation for 24 h, 20 µL of MTT solution (5 mg/mL in PBS as stock solution) were added to each well, and the cells were incubated again at 37℃ for 3 h. The supernatants were removed, and DMSO (200 µL) was then added to each well. The plates were read at 560 nm to obtain the percentage of viable cells.

Measurement of gene expression in primary chondrocytes
------------------------------------------------------

Chondrocytes were plated at a density of 5 × 10^5^ cells/well in 6-well plate and incubated for 24 h. The HF extracts (0-1,000 µg/mL) were applied and the cells stimulated by the addition of LPS 50 µg/mL or H~2~O~2~ 800 µM. After incubation for 24 h, mRNA was extracted from seeding cells using the RNeasy Mini Kit (QIAGEN, Maryland, USA) and cDNA was prepared using the iScript™ cDNA Synthesis kit (BIORAD, Hercules, CA, USA). Real-Time PCR (Applied Biosystems, Foster City, CA, USA) was performed using the cDNA (1 µL) with the SYBR Green PCR Master Mix (iQ SYBR Green Supermix, BIORAD, Hercules, CA, USA). The cDNA was amplified for 40 cycles of denaturation (95℃ for 30 s), annealing (58℃ for 30 s), and extension (72℃ for 45 s) using the following primers: GAPDH forward primer 5\'-TGG CCT CCA AGG AGT AAG AAA C-3\', reverse primer 5\'-CAG CAA CTG AGG GCC TCT CT-3\'; Aggrecan forward primer 5\'-GAA GTG GCG TCC AAA CCA A-3\', reverse primer 5\'-CGT TCC ATT CAC CCC TCT CA-3\'; Collagen Type I forward primer 5\'-GAG CGG AGA GTA CTG GAT CGA-3\', reverse primer 5\'-CTG ACC TGT CTC CAT GTT GCA-3\'; Collagen Type II forward primer 5\'-GCA ACA GCA GGT TCA CGT ACA-3\', reverse primer 5\'-TCG GTA CTC GAT GAT GGT CTT G-3\'; TIMP-1 forward primer 5\'-AAG GGC TAC CAG AGC GAT CA, reverse primer 5\'-ATC GAG ACC CCA AGG TAT TGC-3\'; TIMP-3 forward primer 5\'-GAC CGA CAT GCT CTC CAA TTT C-3\', reverse primer 5\'-GCT GCA GTA GCC ACC CTT CT-3\'; MMP-3 forward primer 5\'-GAG TGT GGA TTC TGC CAT TGA G-3\', reverse primer 5\'-TTA TGT CAG CCT CTC CTT CAG AGA-3\'; MMP-7 forward primer 5\'-ACT CTA GGC CAT GCC TTT GC-3\', reverse primer 5-\'CCA TCC GTC CAG TAC TCA TCC T-3\'; TNF-α forward primer 5\'-ACA AGG CTG CCC CGA CTA T-3\', reverse primer 5\'-CTC CTG GTA TGA AGT GGC AAA TC-3\'; IL-6 forward primer 5\'-GCC CTT CAG GAA CAG CTA TGA-3\'; reverse primer 5\'-TGT CAA CAA CAT CAG TCC CAA GA-3\'. Data analysis of real-time RT-PCR results and calculations of the relative quantitation were performed using the 7500 System SDS software version 1.3.1 (Applied Biosystems, Foster City, CA, USA).

Animals and treatment
---------------------

Male Sprague-Dawley rats (6 weeks old) were obtained from Japan SLC, Inc. (Hamamatsu, Japan) and housed at the animal facilities of Kyung Hee University (Yongin, Republic of Korea). The study was approved by the Institutional Animal Care and Use Committee of Kyung Hee University (KHUASP(SE)-15-020). After three days of accommodation, the rats were randomly assigned to five groups (8 rats per group); 1) Normal group (wild type) with AIN-93G rodent diet, 2) arthritis group (sham) with AIN-93G rodent diet, 3) arthritis group (RH) with AIN-93G + Rose Hip extract 500 mg/kg/bw, 4) arthritis group (HFE250) with AIN-93G + *Hijikia fusiforme* 20% ethanol extract 250 mg/kg/bw, 5) arthritis group (HFE500) with AIN-93G + *Hijikia fusiforme* 20% ethanol extract 500 mg/kg/bw. Three days after income, their respective sample was administered orally for 26 days ([Table 1](#T1){ref-type="table"}).

Induction of osteoarthritis
---------------------------

Male Sprague-Dawley rats (SLC Inc., Hamamatsu, Japan) weighing 200-250 g at the time of induction were used. Animals were anaesthetized using isofluorane and a single injection of 50 µL sterile 0.9% saline containing 3 mg of monosodium-iodoacetate (MIA, Sigma) was injected through the articular cavity using a 27 G needle. Normal group injections used 0.9% saline only. Rats were sacrificed by cervical dislocation on day 24 post-MIA injection.

Nitric oxide (NO) production
----------------------------

Serum samples were obtained from rats by aspirating retro-orbital blood on day 24 post-MIA injection. All samples were stored at -80℃ until used. A spectrophotometric method based on the Griess reaction with sodium nitrite as standard was used. Briefly, 50 µL of serums were mixed with 50 µL of Griess reagent (Sigma-aldrich, St Louis, Mo, USA), followed by incubation for 5 min at 37℃. Optical density was measured at 540 nm using an ELISA reader (VERSAMAXSL-20 Molecular Devices, Korea).

Prostaglandin E~2~ (PGE~2~) production
--------------------------------------

Serum samples were obtained from rats by aspirating retro-orbital blood on day 24 post-MIA injection. All samples were stored at -80℃ until used. Serum level of PGE~2~ was determined using ELISA kits (KGE004B, R&D system, Minneapolis, MN, USA), according to the manufacturer\'s instructions.

Measurement of gene expression in osteoarthritis rat cartilage
--------------------------------------------------------------

mRNA was extracted from MIA-induced arthritis rat articular cartilage using the RNeasy Mini Kit (QIAGEN, Maryland, USA) and cDNA was prepared using the iScript™ cDNA Synthesis kit (BIORAD, Hercules, CA, USA). Real-Time PCR (Applied Biosystems, Foster City, CA, USA) was performed using the cDNA (1 µL) with the SYBR Green PCR Master Mix (iQ SYBR Green Supermix, BIORAD, Hercules, CA, USA). The cDNA was amplified for 40 cycles of denaturation (95℃ for 30 s), annealing (58℃ for 30 s), and extension (72℃ for 45 s) using the following primers: GAPDH forward primer 5\'-TGG CCT CCA AGG AGT AAG AAA C-3\', reverse primer 5\'-CAG CAA CTG AGG GCC TCT CT-3\'; Aggrecan forward primer 5\'-GAA GTG GCG TCC AAA CCA A-3\', reverse primer 5\'-CGT TCC ATT CAC CCC TCT CA-3\'; Collagen Type I forward primer 5\'-GAG CGG AGA GTA CTG GAT CGA-3\', reverse primer 5\'-CTG ACC TGT CTC CAT GTT GCA-3\'; Collagen Type II forward primer 5\'-GCA ACA GCA GGT TCA CGT ACA-3\', reverse primer 5\'-TCG GTA CTC GAT GAT GGT CTT G-3\'; MMP-3 forward primer 5\'-GAG TGT GGA TTC TGC CAT TGA G-3\', reverse primer 5\'-TTA TGT CAG CCT CTC CTT CAG AGA-3\'; MMP-7 forward primer 5\'-ACT CTA GGC CAT GCC TTT GC-3\', reverse primer 5-\'CCA TCC GTC CAG TAC TCA TCC T-3\'. Data analysis of real-time RT-PCR results and calculations of the relative quantitation were performed using the 7500 System SDS software version 1.3.1 (Applied Biosystems, Foster City, CA, USA).

Statistical analysis
--------------------

The experimental results are presented as the means ± SD. The significance of treatment effects was assessed using Duncan\'s multiple range tests following one-way analysis of variance (ANOVA) using the SAS 9.2 version software (SAS Institute Inc., Cary, NC, USA). *P* \< 0.05 was considered to indicate a statistically significant difference.

RESULTS
=======

Effects of the Hijikia fusiforme extracts on the cell viability of chondrocytes
-------------------------------------------------------------------------------

The HW and ET20 did not affect the chondrocyte viability, but the viability of ET50-treated chondrocytes was significantly decreased at 600 µg/mL (*P* \< 0.05) ([Fig. 1](#F1){ref-type="fig"}). Therefore, we decided to examine the effects of HW 0-1,000 µg/mL, ET 0-1,000 µg/mL, and ET50 0-500 µg/mL.

Protective effects of the Hijikia fusiforme extracts on H~2~O~2~-induced chondrocytes
-------------------------------------------------------------------------------------

The H~2~O~2~-induced chondrocytes showed significantly reduced cell viability to approximately 43.3% of normal chondrocyte viability. In the HW, ET20, and ET50, cell viability was significantly increased compared with that of the H~2~O~2~-induced chondrocyte control group (*P* \< 0.05) ([Fig. 2](#F2){ref-type="fig"}).

Effects of the Hijikia fusiforme extracts on the expression of TNF-α and IL-6 in chondrocytes
---------------------------------------------------------------------------------------------

We found that *Hijikia fusiforme* inhibited LPS-mediated TNF-α and IL-6 gene expression in chondrocytes. HW, ET20, and ET50 inhibited TNF-α and IL-6 expression in a dose-dependent manner. In particular, TNF-α expression in 1,000 µg/mL ET20-treated cells was significantly decreased by 1.30 ± 0.04 compared with LPS treated cells (2.93 ± 0.10) (*P* \< 0.05) ([Fig. 3A](#F3){ref-type="fig"}). In addition, IL-6 expression in 1,000 µg/mL ET20-treated cells also was significantly decreased by 1.15 ± 0.06 compared with LPS treated cells (3.29 ± 0.20) (*P* \< 0.05) ([Fig. 3B](#F3){ref-type="fig"}).

Effects of the Hijikia fusiforme extracts on genetic expression of anabolic and catabolic factors in chondrocytes
-----------------------------------------------------------------------------------------------------------------

We examined whether a *Hijikia fusiforme* inhibited H~2~O~2~ mediated type I collagen, type II collagen, aggrecan, TIMP-1, TIMP-3, MMP-3, and MMP-7 expression in chondrocytes. Expression of type I collagen, type II collagen, aggrecan, TIMP-1, and TIMP-3 was significantly decreased in 800 µM H~2~O~2~ treated-chondrocytes compared with normal chondrocytes. However, H~2~O~2~ treated-chondrocytes with HW, ET20, and ET50 showed a significant dose-dependent decrease in expression of type I collagen, type II collagen, aggrecan, TIMP-1, and TIMP-3 compared with that of H~2~O~2~ treated-chondrocytes. In particular, expression of type I collagen, type II collagen, aggrecan, TIMP-1, and TIMP-3 in 1,000 µg/mL ET20-treated chondrocytes showed the most significant increase compared with that of H~2~O~2~ treated-chondrocytes (*P* \< 0.05) ([Fig. 4](#F4){ref-type="fig"}).

Expression of MMP-3 and MMP-7 was significantly increased in 800 µM H~2~O~2~-treated chondrocytes compared with normal chondrocytes. In contrast, expression of MMP-3 and MMP-7 in 1,000 µg/mL ET20-treated chondrocytes showed the most significant decrease compared with that of H~2~O~2~ treated-chondrocytes (*P* \< 0.05) ([Fig. 5](#F5){ref-type="fig"}).

We confirmed that the effect of ET20 could improve inflammation and degradation of matrix more than HW and ET50 in osteoarthritis-like chondrocytes. Therefore, we examined the effect of ET20 in an osteoarthritis-induced animal model.

Effects of Hijikia fusiforme on nitric oxide production in an osteoarthritis-induced animal model
-------------------------------------------------------------------------------------------------

To examine whether a HFE can modulate the inflammatory process by regulating the secretion of NO, we measured the serum levels of NO. As illustrated in [Fig. 6](#F6){ref-type="fig"}, a substantial increase in the NO level was detected in the serum of the sham group on day 24 post-MIA injection. In contrast, the NO level in RH treated cells was significantly decreased by 1.63 ± 0.01 compared with the sham group. The HFE250 and HFE500 groups showed significantly decreased levels of NO in serum compared with the sham group (*P* \< 0.05) ([Fig. 6](#F6){ref-type="fig"}).

Effects of Hijikia fusiforme on prostaglandin E~2~(PGE~2~) production in an osteoarthritis-induced animal model
---------------------------------------------------------------------------------------------------------------

The PGE~2~ level in the serum of the sham group was significantly increased compared with that of the normal control group. Treatment with HFE500 resulted in a significant decrease in the PGE~2~ level in the serum compared with that in the sham group (*P* \< 0.05) ([Fig. 7](#F7){ref-type="fig"}).

Effects of Hijikia fusiforme on genetic expression of anabolic and catabolic factors in an osteoarthritis-induced animal model
------------------------------------------------------------------------------------------------------------------------------

Expression of type I collagen, type II collagen, and aggrecan was significantly decreased in the sham group compared with that in the normal control group. In contrast, a significant increase in the expression of type I collagen, type II collagen, and aggrecan was observed in the HFE groups compared with that of the sham group, and it increased in a dose-dependent manner (*P* \< 0.05) ([Fig. 8](#F8){ref-type="fig"}).

Expression of MMP-3 and MMP-7 was significantly increased in the sham group compared with that in the normal control group. Compared with the sham group, oral administration with HFE caused a significant dose-dependent decrease in expression of MMP-3 and MMP-7 (*P* \< 0.05) ([Fig. 9](#F9){ref-type="fig"}).

DISCUSSION
==========

Progression of degenerative osteoarthritis is characterized by changes in extracellular matrix composition, including the degradation of collagen and aggrecan, which can induce the loss of articular cartilage. The major components of the extracellular matrix such as type I collagen, type II collagen, and aggrecan are synthesized and controlled by chondrocytes. Therefore, chondrocytes have been used in *in vitro* models for osteoarthritis experiments \[[@B17][@B18][@B19]\]. In the current study, LPS or H~2~O~2~ was used for induction of osteoarthritis-like inflammation in chondrocytes \[[@B17][@B18][@B19]\]. We confirmed that HW, ET20, and ET50 could improve inflammation and degradation of matrix in LPS or H~2~O~2~-induced chondrocytes through increases in the expression of type I collagen, type II collagen, aggrecan, TIMP-1, and TIMP-3 and decreases in expression of TNF-α, IL-6, MMP-3, and MMP-7.

Pro-inflammatory cytokines (IL-6 and TNF-α) in osteoarthritis affect the catabolism of cartilage tissue. Chondrocytes in osteoarthritis constitutively exhibit the activation of response for inflammation and the expression of MMPs to degradation of extracellular matrix proteins \[[@B20][@B21]\]. MMPs play an important role in the process in normal tissue of differentiation, wound healing, re-formation, organ formation, reproductive, blood vessel formation, tissue absorption and organization, and it is also expressed in pathological conditions such as arthritis for an important role in the pathogenesis \[[@B22]\]. Catrina et al. \[[@B20]\] showed that anti-TNF-α therapy significantly down-regulated serum levels of MMP-1 and MMP-3 and the ratio of MMPs to tissue inhibitor of metalloproteinase (TIMP)-1 in arthritis patients. Some studies have reported that IL-6 induced bone resorption by stimulating the recruitment and formation of osteoclasts \[[@B21]\]. Houssiau et al. \[[@B21]\] reported that IL-6 activity was significantly elevated in synovial fluid from patients with arthritis or other inflammatory arthritides.

In this current study, we found a marked increase in the expression of IL-6 and TNF-α in LPS-induced chondrocytes and in the expression of MMP-3 and MMP-7 in H~2~O~2~-induced chondrocytes. However, HW, ET20, and ET50 induced the repression of changes in the expression induced by LPS and H~2~O~2~. According to these reports and our results, we suggest that expression of matrix proteins such as collagens and aggrecan may improve by inhibiting the activation of response of pro-inflammatory cytokines.

Many studies have clearly indicated an important role of PGE~2~ and NO mediated by inflammation and pain in osteoarthritis \[[@B23][@B24][@B25][@B26][@B27]\]. NO, which is normally generated by iNOS, plays an important role in primary immune defense, and in physiological regulation such as blood vessel expansion \[[@B23]\]. However, when it is expressed excessively, NO is the factor that induces an inflammatory response and cellular necrosis. In addition, NO can cause dilation of blood vessels and increase the TNF-α of permeability in the articulation. As a result, it induces the apoptosis mechanisms of cartilage cells \[[@B24]\]. PGE~2~, which is produced by such as TNF-α in inflammatory reactions, is a factor involved in the development of articular cartilage degradation of osteoarthritis \[[@B25][@B26]\]. In addition, by forming the osteophytes of PGE~2~, it shows abnormal growth goals and pain, these symptoms are known to occur frequently in degenerative arthritis \[[@B27]\].

In the current study, we used the MIA injection-induced rat model for examination of effects of HFE extract on osteoarthritis. MIA injection disrupts chondrocyte metabolism and produces cartilage degeneration, which is similar to the histopathology of the degenerating joint seen in the human osteoarthritis \[[@B28]\]. We found that the NO and PGE~2~ levels were significantly increased in the serum of the sham group compared with that of the normal control group. In addition, in the sham group, the genetic expression of type I collagen, type II collagen, and aggrecan was significantly decreased and the expression of MMP-3 and MMP-7 was significantly increased in the sham group compared with that in the normal control group. However, oral administration of ET20 (HFE), the best effects *in vitro* assay, caused significant decreases in NO, PGE~2~, MMP-3, and MMP-7 and significant increases in type I collagen, type II collagen, and aggrecan in a dose-dependent manner compared with that in the normal control group. The study by Kim et al. \[[@B29]\] reported that 5-hydroxy-3,6,7,8,3\',4\'-hexamethoxyflavone (5HHMF), a polyhydroxyflavone isolated from *Hizikia fusiforme*, inhibited the production of PGE~2~, NO, and pro-inflammatory cytokines and decreased the transcriptional levels in LPS stimulated RAW 264.7 murine macrophage cells. According to this study and our current results, we suggest that *Hizikia fusiforme* may improve inflammation, which may be attributed to the inhibition of production of PGE~2~, NO, and pro-inflammatory cytokines.

In conclusion, *Hijikia fusiforme* 20% ethanol extract decreased the articular cartilage damage and development of osteoarthritis by preventing activation of inflammation *in vitro* and *in vivo*. This finding suggests that *Hijikia fusiforme* 20% ethanol extract might be considered as a potential therapeutic treatment for degenerative osteoarthritis.
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![Cell viability of primary cultured rat cartilage cells, determined by MTT reagent, with treatment of HF extracts at various concentrations.\
(A) Hot water extract 100-1,000 µg/mL, (B) 20% EtOH extract 100-1,000 µg/mL, (C) 50% EtOH extract 100-1,000 µg/mL. Data are expressed as mean ± SD (n = 3). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g001){#F1}

![Effect of HF extracts on survival against 800 µM H~2~O~2~ treatment.\
(A) Hot water extract 100-1,000 µg/mL, (B) 20% EtOH extract 100-1,000 µg/mL, (C) 50% EtOH extract 100-1,000 µg/mL. Data are expressed as mean ± SD (n = 3). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g002){#F2}

![Effect of HF extracts on genetic expression of cytokines in primary cultured cells.\
(A) TNF-α, (B) IL-6. HW; Hot water extract 100-1,000 µg/mL, ET20; 20% EtOH extract 100-1,000 µg/mL, ET50; 50% EtOH extract 100-1,000 µg/mL. Data are expressed as mean ± SD (n = 3). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g003){#F3}

![Effect of HF extracts on genetic expression of anabolic factors in primary cultured cells.\
(A) Col-1, (B) Col-2, (C) Aggrecan, (D) TIMP-1, (E) TIMP-3. HW; Hot water extract 100-1,000 µg/mL, ET20; 20% EtOH extract 100-1,000 µg/mL, ET50; 50% EtOH extract 100-1,000 µg/mL. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g004){#F4}

![Effect of HF extracts on genetic expression of catabolic factors in primary cultured cells.\
(A) MMP-3, (B) MMP-7. HW; Hot water extract 100-1,000 µg/mL, ET20; 20% EtOH extract 100-1,000 µg/mL, ET50; 50% EtOH extract 100-1,000 µg/mL. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g005){#F5}

![Inhibitory effects of HFE on serum NO level.\
Normal control; Not injection + AIN 93G, Sham; Injection MIA + AIN 93G, RH500; Injection MIA + AIN 93G + Rose Hip extract 500 µg/kg, HFE 250; *Hijikia fusiforme* 20% EtOH extract 250 µg/kg, HFE 500; *Hijikia fusiforme* 20% EtOH extract 500 µg/kg. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g006){#F6}

![Inhibitory effects of HFE on serum PGE~2~ level.\
Normal control; Not injection + AIN 93G, Sham; Injection MIA + AIN 93G, RH500; Injection MIA + AIN 93G + Rose Hip extract 500 µg/kg, HFE 250; *Hijikia fusiforme* 20% EtOH extract 250 µg/kg, HFE 500; *Hijikia fusiforme* 20% EtOH extract 500 µg/kg. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g007){#F7}

![Genetic expression of anabolic factors in MIA rat articular cartilage.\
Normal control; Not injection + AIN 93G, Sham; Injection MIA + AIN 93G, RH500; Injection MIA + AIN 93G + Rose Hip extract 500 µg/kg, HFE 250; *Hijikia fusiforme* 20% EtOH extract 250 µg/kg, HFE 500; *Hijikia fusiforme* 20% EtOH extract 500 µg/kg. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g008){#F8}

![Genetic expression of catabolic factors in MIA rat articular cartilage.\
Normal control; Not injection + AIN 93G, Sham; Injection MIA + AIN 93G, RH500; Injection MIA + AIN 93G + Rose Hip extract 500 µg/kg, HFE 250; *Hijikia fusiforme* 20% EtOH extract 250 µg/kg, HFE 500; *Hijikia fusiforme* 20% EtOH extract 500 µg/kg. Data are expressed as mean ± SD (n = 8/group). Significant differences were determined using Duncan\'s multiple range test at *P* \< 0.05.](nrp-10-265-g009){#F9}
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